The role of urocortin in gynecological and obstetrical conditions

[1]  Lu Gao,et al.  Differential regulation of prostaglandin production mediated by corticotropin-releasing hormone receptor type 1 and type 2 in cultured human placental trophoblasts. , 2008, Endocrinology.

[2]  F. Petraglia,et al.  Evaluation of endometrial urocortin secretion for prediction of pregnancy after intrauterine insemination. , 2008, Clinical chemistry.

[3]  F. Petraglia,et al.  Prediction of preterm delivery based on maternal plasma urocortin. , 2007, The Journal of clinical endocrinology and metabolism.

[4]  Jing Xu,et al.  Expression and role of the corticotropin-releasing hormone/urocortin-receptor-binding protein system in the primate corpus luteum during the menstrual cycle. , 2007, Endocrinology.

[5]  F. Petraglia,et al.  Plasma Urocortin Levels in the Diagnosis of Ovarian Endometriosis , 2007, Obstetrics and gynecology.

[6]  T. Reimer,et al.  Abortion is associated with increased expression of FasL in decidual leukocytes and apoptosis of extravillous trophoblasts: a role for CRH and urocortin. , 2007, Molecular human reproduction.

[7]  T. Kozicz.  On the role of urocortin 1 in the non-preganglionic Edinger-Westphal nucleus in stress adaptation. , 2007, General and comparative endocrinology.

[8]  P. He,et al.  Corticotropin-releasing hormone receptor type 1 and type 2 mediate differential effects on 15-hydroxy prostaglandin dehydrogenase expression in cultured human chorion trophoblasts. , 2007, Endocrinology.

[9]  W. Pan,et al.  Corticotropin-releasing hormone receptor (CRHR)1 and CRHR2 are both trafficking and signaling receptors for urocortin. , 2007, Molecular endocrinology.

[10]  A. Makrigiannakis,et al.  Expression of urocortin in the extravillous human trophoblast at the implantation site. , 2007, Placenta.

[11]  F. Petraglia,et al.  Human endometrium expresses urocortin II and III messenger RNA and peptides. , 2006, Fertility and sterility.

[12]  F. Petraglia,et al.  Urocortin expression is downregulated in human endometrial carcinoma. , 2006, The Journal of endocrinology.

[13]  F. Petraglia,et al.  Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes. , 2006, American journal of obstetrics and gynecology.

[14]  C. Donaldson,et al.  Urocortin 2-Deficient Mice Exhibit Gender-Specific Alterations in Circadian Hypothalamus–Pituitary–Adrenal Axis and Depressive-Like Behavior , 2006, The Journal of Neuroscience.

[15]  F. Petraglia,et al.  Maternal plasma corticotrophin-releasing factor and urocortin levels in post-term pregnancies. , 2006, European journal of endocrinology.

[16]  J. Challis,et al.  Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes. , 2005, The Journal of clinical endocrinology and metabolism.

[17]  J. Tao,et al.  Effects of urocortin via ion mechanisms or CRF receptors? , 2005, Biochemical and biophysical research communications.

[18]  W. Rainey,et al.  Corticotropin-releasing hormone (CRH) and urocortin act through type 1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. , 2005, The Journal of clinical endocrinology and metabolism.

[19]  F. Petraglia,et al.  High fetal urocortin levels at term and preterm labor. , 2005, The Journal of clinical endocrinology and metabolism.

[20]  Joachim Spiess,et al.  Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2 , 2005, FEBS letters.

[21]  E. Karteris,et al.  Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. , 2005, The Journal of clinical endocrinology and metabolism.

[22]  F. Petraglia,et al.  Reduced Maternal Plasma Urocortin Concentrations and Impaired Uterine Artery Blood Flow at Human Mid Pregnancy , 2005, The Journal of the Society for Gynecologic Investigation: JSGI.

[23]  H. Sasano,et al.  Localization and physiological roles of urocortin , 2004, Peptides.

[24]  F. Petraglia,et al.  Urocortins in human reproduction , 2004, Peptides.

[25]  K. Takahashia,et al.  Urocortins as cardiovascular peptides , 2004, Peptides.

[26]  R. Ziegler,et al.  mRNA expression profiles for corticotrophin-releasing hormone, urocortin, CRH-binding protein and CRH receptors in human term gestational tissues determined by real-time quantitative RT-PCR. , 2004, Journal of molecular endocrinology.

[27]  K. Catt,et al.  Corticotropin releasing hormone receptors: two decades later , 2004, Peptides.

[28]  E. Karteris,et al.  Expression and signalling characteristics of the corticotrophin-releasing hormone receptors during the implantation phase in the human endometrium. , 2004, Journal of molecular endocrinology.

[29]  E. Karteris,et al.  Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility. , 2004, Endocrinology.

[30]  T. Theoharides,et al.  High levels of intrauterine corticotropin-releasing hormone, urocortin, tryptase, and interleukin-8 in spontaneous abortions. , 2003, Endocrinology.

[31]  D. Grammatopoulos,et al.  Role of stress peptides during human pregnancy and labour. , 2002, Reproduction.

[32]  F. Petraglia,et al.  Levels of Maternal Plasma Corticotropin-Releasing Factor and Urocortin During Labor , 2002, The Journal of the Society for Gynecologic Investigation: JSGI.

[33]  L. Monge,et al.  Relaxation by urocortin of human saphenous veins , 2002, British journal of pharmacology.

[34]  F. Petraglia,et al.  Identification of urocortin mRNA and peptide in the human endometrium. , 2002, The Journal of endocrinology.

[35]  G. Coukos,et al.  Corticotropin-releasing hormone promotes blastocyst implantation and early maternal tolerance , 2001, Nature Immunology.

[36]  H. Randeva,et al.  Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals: implications for adrenal function and energy homeostasis. , 2001, The Journal of clinical endocrinology and metabolism.

[37]  H. Randeva,et al.  Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals. , 2001, The Journal of clinical endocrinology and metabolism.

[38]  F. Petraglia,et al.  Changes in inhibins and activin secretion in healthy and pathological pregnancies , 2001, Molecular and Cellular Endocrinology.

[39]  D. Latchman.  Urocortin protects against ischemic injury via a MAPK-dependent pathway. , 2001, Trends in cardiovascular medicine.

[40]  C. Donaldson,et al.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Hsueh,et al.  Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor , 2001, Nature Medicine.

[42]  C. May,et al.  Cardiovascular actions of CRH and urocortin: an update , 2001, Peptides.

[43]  M. Hongo,et al.  Urocortin and corticotropin-releasing factor receptor expression in normal cycling human ovaries. , 2001, The Journal of clinical endocrinology and metabolism.

[44]  J. Vaughan,et al.  Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  H. Randeva,et al.  Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins. , 2000, Molecular endocrinology.

[46]  R. Smith,et al.  Localization and characterization of urocortin during human pregnancy. , 2000, Placenta.

[47]  D. Grammatopoulos,et al.  Role of corticotropin-releasing hormone in onset of labour , 1999, The Lancet.

[48]  F. Petraglia,et al.  Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. , 1999, The Journal of clinical endocrinology and metabolism.

[49]  F. Petraglia,et al.  Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. , 1999, The Journal of clinical endocrinology and metabolism.

[50]  W. Walters,et al.  Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. , 1998, The Journal of clinical endocrinology and metabolism.

[51]  E. Linton,et al.  Urocortin in pregnancy. , 1998, American journal of obstetrics and gynecology.

[52]  R. Knight,et al.  Expression and protective effects of urocortin in cardiac myocytes , 1998, Neuropeptides.

[53]  S. Yen,et al.  Expression of genes encoding corticotropin-releasing factor (CRF), type 1 CRF receptor, and CRF-binding protein and localization of the gene products in the human ovary. , 1997, The Journal of clinical endocrinology and metabolism.

[54]  J. Vaughan,et al.  Human placenta and fetal membranes express human urocortin mRNA and peptide. , 1996, The Journal of clinical endocrinology and metabolism.

[55]  David Lovejoy,et al.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor , 1995, Nature.

[56]  R. Smith,et al.  Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathway. , 1995, The Journal of clinical endocrinology and metabolism.

[57]  F. Petraglia,et al.  Corticotropin releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[58]  M. Mclean,et al.  A placental clock controlling the length of human pregnancy , 1995, Nature Medicine.

[59]  C. Redman,et al.  Corticotrophin‐releasing hormone and corticotrophin‐ releasing hormone binding protein in normal and pre‐eclamptic human pregnancies , 1995, British journal of obstetrics and gynaecology.

[60]  T. Lovenberg,et al.  Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Challis,et al.  The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. , 1991, The Journal of clinical endocrinology and metabolism.

[62]  S. Brennecke,et al.  Role of endothelium-derived nitric oxide in maintenance of low fetal vascular resistance in placenta , 1990, The Lancet.

[63]  J. Challis,et al.  Local stimulation of prostaglandin production by corticotropin-releasing hormone in human fetal membranes and placenta. , 1989, Biochemical and biophysical research communications.

[64]  T. Wahlström,et al.  Corticotrophin-releasing factor in human placenta: localization, concentration and release in vitro. , 1988, Placenta.

[65]  F. Petraglia,et al.  Secretory endometrium highly expresses urocortin messenger RNA and peptide: possible role in the decidualization process. , 2007, Human reproduction.

[66]  Kazuhiro Takahashi,et al.  Urocortins as cardiovascular peptides. , 2004, Peptides.

[67]  A. Goumenou,et al.  Reduced expression of corticotropin-releasing hormone receptor type-1 alpha in human preeclamptic and growth-restricted placentas. , 2003, The Journal of clinical endocrinology and metabolism.

[68]  D. Latchman.  Molecules in focus: Urocortin , 2002 .

[69]  F. Petraglia,et al.  Lack of gestation-related changes of urocortin gene expression in human placenta , 1999 .

[70]  F. Petraglia,et al.  UROCORTIN STIMULATES PLACENTAL ADRENOCORTICOTROPIN AND PROSTGLANDIN RELEASE AND MYOMETRICAL CONCTRACTILY , 1999 .